Maia Biotechnology, Inc. · AMEX:MAIA
Maia Biotechnology, Inc. shareholders
As of Jun 30, 2026, 34 institutions reported holding Maia Biotechnology, Inc., 22.2% of its shares. Largest: Solas Capital Management, LLC, Vanguard and Alyeska Investment Group, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Maia Biotechnology, Inc. | Change | Filed |
|---|---|---|---|---|
| Solas Capital Management, LLC | 3.03M | 5.0% | −1.27M | Aug 14, 2026 |
| Vanguard | 2.76M | 4.5% | +477K | Aug 13, 2026 |
| Alyeska Investment Group, L.P. | 2.5M | 4.1% | no change | Aug 14, 2026 |
| 683 Capital Management, LLC | 1.07M | 1.8% | no change | Aug 14, 2026 |
| Centric Wealth Management | 797K | 1.3% | no change | Aug 6, 2026 |
| Cable Car Capital, LP | 515K | 0.85% | −134K | Aug 14, 2026 |
| Geode Capital | 504K | 0.83% | +144K | Aug 12, 2026 |
| Bleichroeder LP | 500K | 0.82% | no change | Aug 13, 2026 |
| Renaissance Technologies | 416K | 0.68% | new | Aug 13, 2026 |
| BlackRock | 403K | 0.66% | +275K | Aug 7, 2026 |